Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 53901 - 53925 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Oleic Acid	Approved Investigational Vet Approved	SREBF1	6720	downregulated	Oleic Acid results in decreased expression of SREBF1 mRNA	17p11.2	A19957 A23377
Oleic Acid	Approved Investigational Vet Approved	THRSP	7069	downregulated	Oleic Acid results in decreased expression of THRSP mRNA	11q14.1	A23375
Oleic Acid	Approved Investigational Vet Approved	TNF	7124	upregulated	Oleic Acid results in increased expression of TNF mRNA	6p21.33	A23379
Ofloxacin	Approved Investigational	ASAH1	427	upregulated	Ofloxacin results in increased expression of ASAH1 mRNA	8p22	A20430
Ofloxacin	Approved Investigational	MMP13	4322	downregulated	Ofloxacin results in decreased expression of MMP13 mRNA	11q22.2	A21669
Ofloxacin	Approved Investigational	NUPR1	26471	upregulated	Ofloxacin results in increased expression of NUPR1 mRNA	16p11.2	A20430
Ofloxacin	Approved Investigational	PHYH	5264	downregulated	Ofloxacin results in decreased expression of PHYH mRNA	10p13	A20438
Ofloxacin	Approved Investigational	SLC2A1	6513	downregulated	Ofloxacin results in decreased expression of SLC2A1 mRNA	1p34.2	A21670
Olanzapine	Approved Investigational	AKT1	207	upregulated	olanzapine results in increased expression of AKT1 mRNA	14q32.33	A21687
Olanzapine	Approved Investigational	BIK	638	upregulated	olanzapine results in increased expression of BIK mRNA	22q13.2	A21688
Olanzapine	Approved Investigational	HMGCR	3156	upregulated	olanzapine results in increased expression of HMGCR mRNA	5q13.3	A21634
Olanzapine	Approved Investigational	HMGCS1	3157	upregulated	olanzapine results in increased expression of HMGCS1 mRNA	5p12	A21634
Olanzapine	Approved Investigational	LDLR	3949	upregulated	olanzapine results in increased expression of LDLR mRNA	19p13.2	A21634
Olanzapine	Approved Investigational	SC5D	6309	upregulated	olanzapine results in increased expression of SC5D mRNA	11q23.3-q24.1	A21634
Olanzapine	Approved Investigational	SLC2A4	6517	upregulated	olanzapine results in increased expression of SLC2A4 mRNA	17p13.1	A22864
Olanzapine	Approved Investigational	TP53	7157	upregulated	olanzapine results in increased expression of TP53 mRNA	17p13.1	A21688
Oleandrin	Investigational	CXCR1	3577	upregulated	oleandrin results in increased expression of CXCR1 mRNA	2q35	A23380
Oleandrin	Investigational	CXCR2	3579	upregulated	oleandrin results in increased expression of CXCR2 mRNA	2q35	A23380
Oleandrin	Investigational	CXCR4	7852	upregulated	oleandrin results in increased expression of CXCR4 mRNA	2q22.1	A23380
Olodaterol	Approved Investigational	ADRB2	154	upregulated	olodaterol results in increased expression of ADRB2 mRNA	5q32	A23381
Olodaterol	Approved Investigational	EDN1	1906	downregulated	olodaterol results in decreased expression of EDN1 mRNA	6p24.1	A23382
Olomoucine	Experimental	RB1	5925	upregulated	olomoucine results in increased expression of RB1 mRNA	13q14.2	A20412
Olomoucine	Experimental	SP1	6667	upregulated	olomoucine results in increased expression of SP1 mRNA	12q13.13	A20412
Oltipraz	Investigational	ABCB1	5243	upregulated	oltipraz results in increased expression of ABCB1 mRNA	7q21.12	A23383
Oltipraz	Investigational	ABCB11	8647	downregulated	oltipraz results in decreased expression of ABCB11 mRNA	2q31.1	A23383

Displaying entries 53901 - 53925 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability